2.10 Stable angina, acute coronary syndromes and fibrinolysis

For secondary care use only.

Refer to NICE CG 172 MI-Secondary Prevention, for information on secondary prevention in primary and secondary care for patients following a myocardial infarction.

See also rivaroxaban^▼ in Acute Coronary Syndrome.

2.1 Positive inotropic drugs
- 2.1.1 Cardiac glycosides
2.2 Diuretics
2.3 Anti-arrhythmic drugs
- 2.3.2 Drugs for arrhythmias
2.4 Beta-adrenoceptor blocking drugs
2.5 Hypertension and heart failure
2.6 Nitrates, calcium-channel blockers and other antianginal drugs
2.7 Sympathomimetics
2.8 Anticoagulants and protamine
- 2.8.1 Parenteral anticoagulants
- 2.8.2 Oral anticoagulants
2.9 Antiplatelet drugs
2.10 Stable angina, acute coronary syndromes and fibrinolysis
2.11 Antifibrinolytic drugs and haemostatics
2.12 Lipid-regulating drugs

2.10 Stable angina, acute coronary syndromes and fibrinolysis

For secondary care use only.

Contents